Zimmer Biomet Holdings (XSWX:ZBH) Beginning Cash Position: CHF466 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ZBH Zimmer Biomet Holdings Inc XSWX:ZBH
76 GF Score
Price CHF76.50
GF Value CHF102.70
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Beginning Cash Position?

Zimmer Biomet Holdings XSWX:ZBH 76 Beginning Cash Position is CHF466 Mil as of Mar. 2026. GuruFocus rates XSWX:ZBH with a GF Score™ of 76/100 and a GF Value™ of CHF102.70. The stock has 3 warning signs investors should review.

Zimmer Biomet Holdings's Beginning Cash Position for the quarter that ended in Mar. 2026 was CHF466 Mil.

Zimmer Biomet Holdings's quarterly Beginning Cash Position increased from Sep. 2025 (CHF443 Mil) to Dec. 2025 (CHF1,030 Mil) but then declined from Dec. 2025 (CHF1,030 Mil) to Mar. 2026 (CHF466 Mil).

Zimmer Biomet Holdings's annual Beginning Cash Position increased from Dec. 2023 (CHF325 Mil) to Dec. 2024 (CHF371 Mil) and increased from Dec. 2024 (CHF371 Mil) to Dec. 2025 (CHF419 Mil).

Zimmer Biomet Holdings Beginning Cash Position Related Terms

Zimmer Biomet Holdings Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings Beginning Cash Position Chart

Zimmer Biomet Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 738.73 445.77 324.91 370.73 418.77

Zimmer Biomet Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 464.16 1,126.04 443.35 1,030.15 466.00
XSWX:ZBH
76GF Score
Zimmer Biomet Holdings Inc XSWX:ZBH
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zimmer Biomet Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of CHF466 Mil mean?
Zimmer Biomet Holdings (XSWX:ZBH) has a Beginning Cash Position of CHF466 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Zimmer Biomet Holdings and its competitors.
Is Zimmer Biomet Holdings' Beginning Cash Position too high?
Zimmer Biomet Holdings' current Beginning Cash Position is CHF466 Mil. Overall, Zimmer Biomet Holdings has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Beginning Cash Position compare to STE and PEN?
Zimmer Biomet Holdings' Beginning Cash Position of CHF466 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current Beginning Cash Position is CHF466 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Zimmer Biomet Holdings (XSWX:ZBH) has a current Beginning Cash Position of CHF466 Mil. The stock's GF Value™ is CHF102.70, compared to a current price of CHF76.50 — trading 25.5% below its estimated fair value. The current Beginning Cash Position is CHF466 Mil. Zimmer Biomet Holdings' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Beginning Cash Position is CHF466 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF76.50 is trading 25.5% below its estimated GF Value™ of CHF102.70.

Key valuation signals for XSWX:ZBH:

  • Beginning Cash Position: CHF466 Mil
  • GF Value™: CHF102.70 vs. price of CHF76.50 (25.5% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
76GF Score

Get the complete analysis for XSWX:ZBH

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF76.50
Price
CHF102.70
GF Value